Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma
Quantitative Imaging in Medicine and Surgery · 2025-11 · 15 (11) · 11398-11407
DOI: 10.21037/qims-2025-726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quantitative Imaging in Medicine and Surgery, 2025-11. Verfasst von Caiqiang Xue und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The methylation status of the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter profoundly influences the response of glioblastoma (GBM) patients to temozolomide (TMZ) chemotherapy. This study evaluates the potential of magnetic resonance imaging (MRI) fractal analysis to predict the methylation status of the MGMT promoter in isocitrate dehydrogenase (IDH) wild-type GBM.
Methods
In this retrospective study, 303 GBM patients from two centers were included between 2018 and 2023. The training set consisted of 220 patients from the first center, and the independent validation cohort included 83 patients from the second center. Fractal dimension (FD) and lacunarity were extracted from T2-weighted and post-contrast T1-weighted (T1C) MRI sequences. Statistical analyses, including independent t-tests, Chi-squared tests, and multivariate logistic regression, were performed to explore associations between patient characteristics and fractal parameters. Predictive models were developed and assessed using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA).
Results
Significant differences (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Laws and Regulations, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Radiology, Lanzhou University Second Hospital, Lanzhou, China.
- Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China.
- Department of Neurosurgery, Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Hand and Foot Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zitieren
APA
Xue, C., Wang, K., Dong, W., Han, T., Zhou, Q., Zhang, P., Liang, L., Wang, P., Zhou, J., Guan, S., & Liu, X. (2025). Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma. Quantitative Imaging in Medicine and Surgery, 15(11), 11398-11407. https://doi.org/10.21037/qims-2025-726
Vancouver
Xue C, Wang K, Dong W, Han T, Zhou Q, Zhang P, et al. Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma. Quantitative Imaging in Medicine and Surgery. 2025;15(11):11398-11407. doi:10.21037/qims-2025-726
BibTeX
@article{Xue2025,
author = {Xue, Caiqiang and Wang, Kun and Dong, Wenjie and Han, Tao and Zhou, Qing and Zhang, Peng and Liang, Lijun and Wang, Ping and Zhou, Junlin and Guan, Shibing and Liu, Xuejun},
title = {Magnetic resonance imaging fractal analysis of O(6)-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase wild-type glioblastoma},
journal = {Quantitative Imaging in Medicine and Surgery},
year = {2025},
volume = {15},
number = {11},
pages = {11398--11407},
doi = {10.21037/qims-2025-726}
}
EUVIMED